down arrow

ANG Lifesciences

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE236W01016
  • NSEID:
  • BSEID: 540694
INR
29.34
-0.15 (-0.51%)
BSENSE

Apr 11, 12:46 PM

BSE+NSE Vol: 2.11 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About ANG Lifesciences India Ltd stock-summary
stock-summary
ANG Lifesciences India Ltd
Micro Cap
Pharmaceuticals & Drugs
ANG Lifesciences India Limited was originally incorporated as a Private Limited Company with the name "ANG Lifesciences India Private Limited" on June 14, 2006. On conversion into Public Limited Company, the name was changed to ANG Lifesciences India Limited on March 02, 2010. The Company further converted into Private Limited Company and the name of the Company was changed to "ANG Lifesciences India Private Limited" on September 22, 2010.
Company Coordinates stock-summary
Company Details
Darbara Complex SCO 113 I Flr, Dist. Shopping Centre B Block Amritsar Punjab : 143001
stock-summary
Tel: 91-0183-5070118/5070119
stock-summary
cs@anglifesciences.com
Registrar Details
Bigshare Services Pvt Ltd , E-2 , Ansa Industrial Estate, Saki Vihar Road, Saki Naka, Andheri (E), Mumbai
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR 13.06 Cr
Number of Shares
1.31 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
29-Nov-2022
1.31
13.06
100000
10
Preferential basis
13-Jul-2022
1.3
12.96
2591657
10
Bonus Issue
22-Sep-2021
1.04
10.37
5183315
10
Bonus Issue
08-Sep-2017
51.83
5.18
1500800
10
Public Issues
29-Mar-2010
36.83
3.68
150000
10
Allotment of Equity To Others
06-Jun-2008
35.33
3.53
289700
10
Allotment of Equity To Others
28-Mar-2008
32.43
3.24
2279449
10
Allotment of Equity To Others
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

44.8775

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Rajesh Gupta (70.41%)

Highest Public shareholder

None

Individual Investors Holdings

25.92%

stock-summary Board of Directors
stock-summary
stock-summary
Management
Designation
Remuneration
Rajesh Gupta
Managing Director
1.08 cr
Saruchi Gupta
Whole Time Director & CFO
47.25 lacs
Sukhpal Singh
Independent Director
60.0 k
Sudesh Kumari
Director
60.0 k
Pawanjit Singh
Independent Director
65.0 k
Chetna
Independent Director
35.0 k
Renu
Company Sec. & Compli. Officer
0
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
Raw Materials Consumed
88.8865
0%
 
100
Raw Materials Consumed
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Medicines
76.04
100.00%
 
100
Medicines
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
25 Cr
(Quarterly Results - Dec 2024)
Net Profit:
-5 Cr
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 38 Cr (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

1.14

stock-summary
Return on Equity

-18.26%

stock-summary
Price to Book

0.54